Larvol Delta - Sixmonth-safety-followup-of-an-adjuvanted-SARSCoV2-trimeric-Sprotein-subunit-vaccine-SCB2019-in-adults-A-phase-23-doubleblind-randomized-study

SCB-2019 - Sichuan Clover Biopharma

adjuvant CpG 1018 - Dynavax

http://www.ncbi.nlm.nih.gov/pubmed/36868877

Mar 4, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next